Oncological Problems in Children
Özet
Childhood cancers are among the leading causes of morbidity and mortality in the pediatric population and differ from adult malignancies in terms of their biological, clinical, and epidemiological characteristics. Leukemias, lymphomas, central nervous system tumors, neuroblastoma, and Wilms tumor are among the most common malignancies in children. Advances in diagnosis and treatment, particularly risk-adapted treatment protocols and supportive care practices, have led to significant improvements in survival rates. Early diagnosis is one of the key determinants of treatment success. Symptoms such as prolonged fever, unexplained weight loss, lymphadenopathy, bone pain, neurological findings, and abdominal masses must be carefully evaluated. The diagnostic process includes a comprehensive clinical evaluation, laboratory tests, imaging studies, and histopathological confirmation. The treatment approach is individualized based on tumor type and disease stage, utilizing chemotherapy, surgical treatment, radiation therapy, stem cell transplantation, immunotherapy, and targeted therapies. Nursing care is an integral component of the treatment process and encompasses medication administration, symptom management, pain control, nutritional support, infection prevention, family-centered care, and psychosocial support. Additionally, nurses assume significant responsibilities in the areas of oncofertility, long-term follow-up of survivors (survivorship), and palliative care. The management of childhood cancers requires a multidisciplinary approach that integrates current treatment strategies, high-quality nursing care, and long-term follow-up.
Çocukluk çağı kanserleri, pediatrik popülasyonda önemli morbidite ve mortalite nedenleri arasında yer almakta olup erişkin malignitelerinden biyolojik, klinik ve epidemiyolojik özellikleri bakımından farklılık göstermektedir. Lösemiler, lenfomalar, santral sinir sistemi tümörleri, nöroblastom ve Wilms tümörü çocuklarda en sık görülen maligniteler arasındadır. Tanı ve tedavi alanındaki gelişmeler, özellikle risk uyarlanmış tedavi protokolleri ve destekleyici bakım uygulamaları sayesinde sağkalım oranlarında belirgin iyileşmeler sağlamıştır. Erken tanı, tedavi başarısının temel belirleyicilerinden biridir. Uzamış ateş, açıklanamayan kilo kaybı, lenfadenopati, kemik ağrısı, nörolojik bulgular ve abdominal kitle gibi belirtilerin dikkatle değerlendirilmesi gerekmektedir. Tanı süreci; kapsamlı klinik değerlendirme, laboratuvar incelemeleri, görüntüleme yöntemleri ve histopatolojik doğrulamayı içermektedir. Tedavi yaklaşımı tümör tipi ve hastalık evresine göre bireyselleştirilmekte; kemoterapi, cerrahi tedavi, radyoterapi, kök hücre nakli, immünoterapi ve hedefe yönelik tedavilerden yararlanılmaktadır. Hemşirelik bakımı ise tedavi sürecinin ayrılmaz bir bileşeni olup ilaç uygulamaları, semptom yönetimi, ağrı kontrolü, beslenme desteği, enfeksiyonların önlenmesi, aile merkezli bakım ve psikososyal desteği kapsamaktadır. Ayrıca hemşireler, onkofertilite, sağ kalan bireylerin uzun dönem izlemi (survivorship) ve palyatif bakım süreçlerinde önemli sorumluluklar üstlenmektedir. Çocukluk çağı kanserlerinin yönetimi, güncel tedavi yaklaşımlarını, nitelikli hemşirelik bakımını ve uzun dönem izlemi bütünleştiren multidisipliner bir yaklaşım gerektirmektedir.
Referanslar
Adamczewska-Wawrzynowicz, K., Wiącek, A., Kozłowska, A., Mikosza, K., Szefler, L., Dudlik, W., … Derwich, K. (2023). Modern treatment strategies in pediatric oncology and hematology. Discover Oncology, 14(1), 98.
Alther, B., Mylius, V., Weller, M., & Gantenbein, A. R. (2020). From first symptoms to diagnosis: Initial clinical presentation of primary brain tumors. Clinical and Translational Neuroscience, 4(2), 2514183X20968368.
Aygüneş, U., & Antmen, A. B. (2024). Clinical characteristics and treatment outcomes of pediatric patients with non-Hodgkin lymphoma: A single-center experience from southern Turkey. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi, 15(4), 334–341.
Chang, J. H. C., Poppe, M. M., Hua, C. H., Marcus, K. J., & Esiashvili, N. (2021). Acute lymphoblastic leukemia. Pediatric Blood & Cancer, 68, e28371.
Children’s Oncology Group. (2024, February 6). Guideline for the management of fatigue in children and adolescents with cancer or pediatric hematopoietic cell transplant recipients: 2023 update (COG-endorsed) [PDF]. Retrieved December 15, 2025, from https://www.childrensoncologygroup.org/docs/default-source/pdf/cog_sc_fatigue_guideline_document.pdf
Children’s Oncology Group. (2025). Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers (Version 6.0). Retrieved December 20, 2025, from https://www.survivorshipguidelines.org/pdf/2025/COG_LTFU_Guidelines_Only_v6.pdf
Comparcini, D., Simonetti, V., Galli, F., Saltarella, I., Altamura, C., Tomietto, M., Desaphy, J.-F., & Cicolini, G. (2023). Immersive and non-immersive virtual reality for pain and anxiety management in pediatric patients with hematological or solid cancer: A systematic review. Cancers, 15(3), 985. https://doi.org/10.3390/cancers15030985
Elgarten, C. W., & Aplenc, R. (2020). Pediatric acute myeloid leukemia: Updates on biology, risk stratification, and therapy. Current Opinion in Pediatrics, 32(1), 57–66.
Erdoğan, B., & Altay, N. (2025). Meaning-making through digital storytelling: Experiences of children and adolescents with cancer within Peplau’s theory and a hermeneutic approach. European Journal of Oncology Nursing, 103076.
Erdoğan, B., Yıldız, S., Bayram, D., Törüner, E. K., & Altay, N. (2023). Back to school readiness scale for children with oncological problems: 7–18 years of age. Journal of Pediatric Nursing, 73, e594–e601.
Kılıçarslan Törüner, E., & Altay, N. (2022). Pediatric hematology oncology nursing [in Turkish: Pediatrik hematoloji onkoloji hemşireliği]. Ankara Nobel Tıp Kitabevleri.
National Cancer Institute. (2025). Cancer in children and adolescents. Retrieved December 16, 2025, from https://www.cancer.gov/types/childhood-cancers/child-adolescent-cancers-fact-sheet
Palmisani, F., Kovar, H., Kager, L., Amann, G., Metzelder, M., & Bergmann, M. (2021). Systematic review of the immunological landscape of Wilms tumors. Molecular Therapy – Oncolytics, 22, 454–467.
Pappo, A. S., & Dirksen, U. (2018). Rhabdomyosarcoma, Ewing sarcoma, and other round cell sarcomas. Journal of Clinical Oncology, 36(2), 168–179.
Su, H. I., Lacchetti, C., Letourneau, J., Partridge, A. H., Qamar, R., Quinn, G. P., … Loren, A. W. (2025). Fertility preservation in people with cancer: ASCO guideline update. Journal of Clinical Oncology, 43(12), 1488–1515.
World Health Organization. (2025). Childhood cancer. Retrieved December 20, 2025, from https://www.who.int/news-room/fact-sheets/detail/cancer-in-children
Yan, A. P., Tomlinson, D., Dupuis, L. L., & Sung, L. (2025). SSPedi and SPARK: Promise for the future of electronic patient-reported outcomes in pediatric oncology. EJC Paediatric Oncology, 100238.
Miranda-Silva, W., Gomes-Silva, W., Zadik, Y., Yarom, N., Al-Azri, A. R., Hong, C. H., … Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). (2021). MASCC/ISOO clinical practice guidelines for the management of mucositis: Sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients. Supportive Care in Cancer, 29(7), 3539–3562.
Lehrnbecher, T., Robinson, P. D., Ammann, R. A., Fisher, B., Patel, P., Phillips, R., … Sung, L. (2023). Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update. Journal of Clinical Oncology, 41(9), 1774–1785.
Muscaritoli, M., Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., … Bischoff, S. C. (2021). ESPEN practical guideline: Clinical nutrition in cancer. Clinical Nutrition, 40(5), 2898–2913.
